Antibiotics: Drug Resistance

(asked on 27th November 2023) - View Source

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what steps his Department is taking to help reduce the threat of antimicrobial resistance to human health from overuse of antibiotics on industrial farms.


Answered by
Mark Spencer Portrait
Mark Spencer
Minister of State (Department for Environment, Food and Rural Affairs)
This question was answered on 5th December 2023

The Government takes a ‘One-Health’ approach to antimicrobial resistance (AMR) as set out in the ‘UK 5-year action plan for antimicrobial resistance 2019 to 2024’, which is underpinned by the UK’s 20-year Vision to Contain and Control AMR by 2040 . Defra is a co-signatory with the Department of Health and Social Care on the 5-year National Acton Plan and 20-year vision on AMR, and Defra leads on delivering the animal, plant and environment elements.

The UK is committed to reducing unnecessary use of antibiotics in animals to reduce the risk of development and spread of AMR in animals and humans. In the UK, we have a well-established antimicrobial use and resistance surveillance programme, which includes monitoring of sales and use of antibiotics in animals as well as routine monitoring of AMR in major food-producing species, healthy pigs and poultry. These surveillance programmes allow us to monitor progress and results are published every year in the UK Veterinary Antibiotic Resistance Sales and Surveillance (UK-VARSS) report.

The recently published UK-VARSS report shows that sales of antibiotics in food producing animals are at their lowest ever level, with a 59% reduction since 2014. This highlights the success of the UK’s voluntary and collaborative approach between Government and the farming and veterinary sectors to make sustainable reductions in antibiotic use whilst ensuring high animal health and welfare. The report also highlights that sales of highest priority, critically important antibiotics (HP-CIAs) have reduced by 82% since 2014 and account for less than half a percent of total sales. This is to ensure that these medically important antibiotics are protected for use in humans.

The newly published third edition of The UK’s One Health report, a joint report from Veterinary Medicines Directorate (VMD) and UK Health and Security Agency (UKHSA), brings together antibiotic use and resistance data for people and animals and sales of antibiotics in 2019 show that approximately two thirds of antibiotics are used in people whilst one third are used in animals. This report demonstrates the UK Government’s One Health approach to tackling AMR to keep antibiotics working in both people and animals.

Reticulating Splines